{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T09:11:46Z","timestamp":1778317906827,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["heartlungcirc.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.hlc.2018.10.016","type":"journal-article","created":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T02:01:59Z","timestamp":1541556119000},"page":"366-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["An Update on the Diagnosis and Management of Catecholaminergic Polymorphic Ventricular Tachycardia"],"prefix":"10.1016","volume":"28","author":[{"given":"Andreas","family":"Pflaumer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2018.10.016_bib0005","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.hlc.2011.10.008","article-title":"Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular Tachycardia","volume":"21","author":"Pflaumer","year":"2012","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2018.10.016_bib0010","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.hrthm.2011.01.048","article-title":"Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia","volume":"8","author":"SY","year":"2011","journal-title":"Heart Rhythm J"},{"key":"10.1016\/j.hlc.2018.10.016_bib0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.yjmcc.2008.10.012","article-title":"Ryanodine receptor and calsequestrin in arrhythmogenesis: what we have learnt from genetic diseases and transgenic mice","volume":"46","author":"Liu","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hlc.2018.10.016_bib0020","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","article-title":"Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia","volume":"119","author":"Hayashi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.10.016_bib0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"106","author":"Priori","year":"2002","journal-title":"Circulation"},{"issue":"November (41)","key":"10.1016\/j.hlc.2018.10.016_bib0030","first-page":"2793","volume":"36","author":"Authors Task Force Members","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2018.10.016_bib0035","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/europace\/eut272","article-title":"Executive summary: HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes","volume":"15","author":"Priori","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.hlc.2018.10.016_bib0040","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/europace\/euw389","article-title":"The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: findings from an international multicentre registry","volume":"20","author":"Roston","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.hlc.2018.10.016_bib0045","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCRESAHA.117.310083","article-title":"Calcium signaling and cardiac arrhythmias","volume":"120","author":"Landstrom","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.hlc.2018.10.016_bib0050","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"8","author":"Ackerman","year":"2011","journal-title":"Heart Rhythm J"},{"key":"10.1016\/j.hlc.2018.10.016_bib0055","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCEP.114.002217","article-title":"Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry","volume":"8","author":"Roston","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hlc.2018.10.016_bib0060","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm J"},{"key":"10.1016\/j.hlc.2018.10.016_bib0065","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/heart.89.1.66","article-title":"Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death","volume":"89","author":"Sumitomo","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.hlc.2018.10.016_bib0070","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.hrthm.2015.09.029","article-title":"Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with \u03b21-selective \u03b2-blockers in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"13","author":"Leren","year":"2016","journal-title":"Heart Rhythm J"},{"key":"10.1016\/j.hlc.2018.10.016_bib0075","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/CIRCRESAHA.116.305347","article-title":"The mechanism of flecainide action in CPVT does not involve a direct effect on RyR2","volume":"116","author":"Bannister","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.hlc.2018.10.016_bib0080","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.hrthm.2013.08.011","article-title":"Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia","volume":"10","author":"Khoury","year":"2013","journal-title":"Heart Rhythm Journal"},{"issue":"7","key":"10.1016\/j.hlc.2018.10.016_bib0085","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/jamacardio.2017.1320","article-title":"Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia: a randomized clinical trial","volume":"2","author":"Kannankeril","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hlc.2018.10.016_bib0090","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/CIRCULATIONAHA.115.015731","article-title":"Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation","volume":"131","author":"De Ferrari","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.10.016_bib0095","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1540-8167.2008.01211.x","article-title":"Sudden death in a young man with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation","volume":"19","author":"Pizzale","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hlc.2018.10.016_bib0100","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/CIRCEP.113.000170","article-title":"Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate","volume":"6","author":"Miyake","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hlc.2018.10.016_bib0105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCEP.113.001217","article-title":"Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis","volume":"7","author":"Tan","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"13","key":"10.1016\/j.hlc.2018.10.016_bib0110","first-page":"e210","article-title":"2017 AHA\/ACC\/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.10.016_bib0115","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.hlc.2011.07.013","article-title":"Guidelines for genetic testing of inherited cardiac disorders","volume":"20","author":"Ingles","year":"2011","journal-title":"Heart Lung Circ"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950618319619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950618319619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T03:34:32Z","timestamp":1548992072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950618319619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1443950618319619"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2018.10.016","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Update on the Diagnosis and Management of Catecholaminergic Polymorphic Ventricular Tachycardia","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2018.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}